• Lixte plans Nasdaq uplisting to accelerate blood cancer trial

    24 days ago - By Fierce Biotech

    Lixte plans Nasdaq uplisting to accelerate blood cancer trial ntaylor
    Fri, 09/04/2020 - 07:50
    Read more ...